Letter

metformin reduces the risk of hepatocellular carcinoma in diabetic patients. Authors' reply

Eduardo Vilar-Gomez, Naga Chalasani

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)838-839
Number of pages2
JournalAlimentary pharmacology & therapeutics
Volume50
Issue number7
DOIs
StatePublished - Oct 1 2019

Fingerprint

Metformin
Hepatocellular Carcinoma

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology
  • Pharmacology (medical)

Cite this

Letter : metformin reduces the risk of hepatocellular carcinoma in diabetic patients. Authors' reply. / Vilar-Gomez, Eduardo; Chalasani, Naga.

In: Alimentary pharmacology & therapeutics, Vol. 50, No. 7, 01.10.2019, p. 838-839.

Research output: Contribution to journalLetter

@article{15ec974b0c54488283dc13eb18c1c62c,
title = "Letter: metformin reduces the risk of hepatocellular carcinoma in diabetic patients. Authors' reply",
author = "Eduardo Vilar-Gomez and Naga Chalasani",
year = "2019",
month = "10",
day = "1",
doi = "10.1111/apt.15486",
language = "English (US)",
volume = "50",
pages = "838--839",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Letter

T2 - metformin reduces the risk of hepatocellular carcinoma in diabetic patients. Authors' reply

AU - Vilar-Gomez, Eduardo

AU - Chalasani, Naga

PY - 2019/10/1

Y1 - 2019/10/1

UR - http://www.scopus.com/inward/record.url?scp=85072300447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072300447&partnerID=8YFLogxK

U2 - 10.1111/apt.15486

DO - 10.1111/apt.15486

M3 - Letter

VL - 50

SP - 838

EP - 839

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 7

ER -